• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    92 Biggest Movers From Friday

    5/9/22 6:27:28 AM ET
    $ACOR
    $ACRX
    $AERI
    $AMLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • Sidus Space, Inc. (NASDAQ:SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.
    • The Arena Group Holdings, Inc. (NYSE:AREN) gained 43.5% to close at $15.00. Arena Group recently posted a Q1 loss of $1.20 per share.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) jumped 30.2% to close at $18.20.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) shares surged 28% to settle at $3.29. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) gained 27.3% to close at $4.10. Tabula Rasa HealthCare recently posted Q1 sales of $83.60 million.
    • Funko, Inc. (NASDAQ:FNKO) rose 26.9% to settle at $21.22 after The Chernin Group announced a consortium led by TCG will make a $263M strategic investment in Funko at $21 per share. Funko also reported upbeat quarterly results.
    • Swvl Holdings Corp. (NASDAQ:SWVL) gained 23.9% to close at $7.47 on Friday. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
    • Mesa Royalty Trust (NYSE:MTR) surged 21.6% to settle at $15.85 amid a gain in oil prices.
    • Forge Global Holdings, Inc. (NYSE:FRGE) rose 20.7% to close at $32.58.
    • Global Cord Blood Corporation (NYSE:CO) gained 19.6% to close at $2.63. Global Cord Blood recently reported the purchase of Cellenkos for $11 per share, for a total value of $664 million.
    • DMC Global Inc. (NASDAQ:BOOM) jumped 19.3% to close at $25.41 following strong Q1 results.
    • Radius Global Infrastructure, Inc. (NASDAQ:RADI) gained 17.7% to close at $14.71.
    • Radius Global was reportedly said to mull options including a sale.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) jumped 17.2% to settle at $7.31.
    • BellRing Brands, Inc. (NASDAQ:BRBR) gained 17.1% to close at $24.42 after the company reported better-than-expected Q2 EPS and sales results.
    • Humanigen, Inc. (NASDAQ:HGEN) jumped 16.9% to settle at $2.15. Humanigen posted a Q1 loss of $0.32 a share.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) gained 16.9% to close at $0.2450.
    • Udemy, Inc. (NASDAQ:UDMY) jumped 16.7% to close at $12.54 after the company reported better-than-expected Q1 EPS and sales results.
    • Cazoo Group Ltd (NYSE:CZOO) surged 15.8% to close at $1.32.
    • Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) gained 15.6% to close at $17.39 following Q1 results.
    • Sequans Communications S.A. (NYSE:SQNS) jumped 15.2% to close at $3.11.
    • Sequans Communications recently posted Q1 adjusted loss of $0.04 per share.
    • Stem, Inc. (NYSE:STEM) rose 15.1% to close at $8.79 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 guidance.
    • Canaan Inc. (NASDAQ:CAN) gained 14.9% to settle at $4.10.
    • Unum Group (NYSE:UNM) gained 13.8% to close at $36.31 following upbeat quarterly earnings.
    • Cypress Environmental Partners, L.P. (NYSE:CELP) rose 13.% to close at $0.4883.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) gained 13% to close at $5.49 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $15 to $20.
    • Turtle Beach Corporation (NASDAQ:HEAR) gained 12.2% to close at $16.62. Turtle Beach weighed a sales process as it considers ways to maximize value for shareholders.
    • Athersys, Inc. (NASDAQ:ATHX) rose 12.2% to settle at $0.6251 following a narrower-than-expected quarterly loss.
    • ChemoCentryx, Inc. (NASDAQ:CCXI) gained 11.1% to close at $17.38 following Q1 results.
    • Cooper-Standard Holdings Inc. (NYSE:CPS) gained 9.7% to close at $6.25 after the company reported better-than-expected Q1 sales results.
    • Adtalem Global Education Inc. (NYSE:ATGE) shares jumped 9.4% to close at $30.87 after the company reported upbeat Q3 results.
    • PepGen Inc. (NASDAQ:PEPG) gained 7.4% to close at $12.89 as the company priced its IPO at $12 per share.
    • Stagwell Inc. (NASDAQ:STGW) gained 7.1% to close at $6.84 after reporting Q1 results.
    • RxSight, Inc. (NASDAQ:RXST) rose 7% to close at $11.35 after the company reported better-than-expected Q1 EPS results.
    • iRhythm Technologies, Inc. (NASDAQ:IRTC) rose 5.8% to close at $124.97 after the company reported better-than-expected Q1 sales results and issued FY22 revenue guidance above analyst estimates.
    • AvidXchange Holdings, Inc. (NASDAQ:AVDX) gained 5.3% to close at $8.14 after the company reported better-than-expected Q1 EPS and sales results and raised FY22 sales guidance above analyst estimates.

     

    Losers

    • Digital Brands Group, Inc.. (NASDAQ:DBGI) shares dipped 54.7% to close at $0.2250 on Friday after the company priced its 37.39 million share offering at $0.25 per share.
    • The Joint Corp. (NASDAQ:JYNT) shares fell 37.9% to close at $17.41 after the company reported downbeat Q1 results.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) dropped 32.6% to close at $0.9914 after HC Wainwright downgraded the stock form Buy to Neutral.
    • Endo International plc (NASDAQ:ENDP) fell 29.7% to close at $1.42 after the company reported Q1 earnings results and issued Q2 guidance.
    • Meten Holding Group Ltd. (NASDAQ:METX) declined 28.2% to close at $1.95 following effectiveness of 1-for-30 reverse stock split.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 27.6% to close at $0.5143 after the company announced a $2 million registered direct offering.
    • Under Armour, Inc. (NYSE:UAA) dropped 23.8% to close at $10.89 after the company reported Q1 adjusted EPS results were down year over year and issued FY23 adjusted EPS guidance below estimates.
    • Guardant Health, Inc. (NASDAQ:GH) fell 22.5% to close at $39.32. Guardant Health's Q1 FY22 revenues rose 22% Y/Y to $96.1 million.
    • SAI.TECH Global Corporation (NASDAQ:SAI) dipped 22.1% to close at $5.25.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 21.4% to close at $0.3030 after the company reported worse-than-expected Q1 EPS results.
    • fuboTV Inc. (NYSE:FUBO) fell 21.1% to close at $3.25 after the company reported Q1 earnings results.
    • Bill.com Holdings, Inc. (NYSE:BILL) declined 20.5% to close at $121.00 after the company reported Q3 earnings results and issued Q4 guidance.
    • Austin Gold Corp. (NYSE:AUST) dropped 20.4% to close at $2.96. Austin Gold recently priced its 3.265 million share IPO at $4 per share.
    • Bloom Energy Corporation (NYSE:BE) shares fell 20.2% to close at $15.13 after the company reported downbeat quarterly results.
    • Zai Lab Limited (NASDAQ:ZLAB) dropped 20.2% to close at $28.55.
    • Remitly Global, Inc. (NASDAQ:RELY) declined 20.1% to close at $8.30 following Q1 results.
    • Bandwidth Inc. (NASDAQ:BAND) dropped 19.9% to close at $21.41. Needham downgraded Bandwidth from Buy to Hold.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 19.7% to close at $0.2570.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) fell 19.7% to close at $1.88. The company is expected to release quarterly results on May 13, 2022.
    • Century Therapeutics, Inc. (NASDAQ:IPSC) declined 19.6% to settle at $8.57.
    • Backblaze, Inc. (NASDAQ:BLZE) dropped 19.3% to close at $7.79 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance.
    • IT Tech Packaging, Inc. (NYSE:ITP) fell 19.2% to close at $0.4038.
    • DISH Network Corporation (NASDAQ:DISH) fell 19.1% to close at $22.22 after the company reported Q1 EPS and sales results down from last year.
    • Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) declined 19% to close at $6.25 following Q1 results.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell 18.8% to settle at $29.82. The U.S. Food and Drug Administration recently issued a Complete Response Letter (CRL) to Axsome Therapeutics regarding its New Drug Application (NDA) for AXS-07 for the acute treatment of migraine.
    • CareDx, Inc (NASDAQ:CDNA) dropped 18.6% to close at $25.78 after the company reported worse-than-expected Q1 EPS results.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) declined 18.6% to close at $0.9683.
    • Vapotherm, Inc. (NYSE:VAPO) fell 18.5% to settle at $3.65. Canaccord Genuity downgraded Vapotherm from Buy to Hold and lowered the price target from $12 to $5.
    • GoPro, Inc. (NASDAQ:GPRO) declined 18.3% to close at $7.15 after the company reported worse-than-expected Q1 sales results.
    • Compass Minerals International, Inc. (NYSE:CMP) fell 18.3% to close at $48.11 following Q1 results.
    • Calyxt, Inc. (NASDAQ:CLXT) dipped 18% to settle at $0.3150 after the company reported Q1 earnings results.
    • Ranpak Holdings Corp. (NASDAQ:PACK) fell 17.6% to close at $12.36 after the company reported worse-than-expected Q1 sales results.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) dropped 17.6% to close at $7.65.
    • PLAYSTUDIOS, Inc. (NASDAQ:MYPS) dipped 17.3% to close at $4.77. PLAYSTUDIOS posted a Q1 loss of $0.20 per share.
    • Burning Rock Biotech Limited (NASDAQ:BNR) fell 17.2% to close at $4.25.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) declined 16.7% to close at $6.38.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) dropped 16.3% to settle at $0.5580. Chembio Diagnostics posted a Q1 loss of $0.29 per share.
    • PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) declined 16% to close at $12.76.
    • Confluent, Inc. (NASDAQ:CFLT) dropped 16% to close at $23.73 after the company reported Q1 earnings results.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 15.8% to close at $39.00.
    • Cloudflare, Inc. (NYSE:NET) fell 15.7% to close at $65.61 after the company reported Q1 earnings results and issued Q2 guidance.
    • Ubiquiti Inc (NYSE:UI) dropped 15.6% to close at $232.79 following Q3 results.
    • Qurate Retail, Inc. (NASDAQ:QRTEA) dropped 15.3% to close at $8.30 after the company reported worse-than-expected Q1 EPS and sales results.
    • Pulmonx Corporation (NASDAQ:LUNG) fell 15.3% to close at $19.16. Pulmonx posted a Q1 loss of $0.43 per share.
    • Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) dropped 14.7% to close at $38.54 after the company reported Q3 earnings results and issued Q4 sales guidance.
    • Illumina, Inc. (NASDAQ:ILMN) fell 14.6% to close at $249.05 after the company reported Q1 financial results.
    • News Corporation (NASDAQ:NWS) fell 13.7% to close at $16.91 after the company reported Q3 financial results.
    • Clean Energy Fuels Corp. (NASDAQ:CLNE) fell 13.6% to close at $5.13 after the company reported worse-than-expected Q1 EPS and sales results.
    • Entravision Communications Corporation (NYSE:EVC) declined 13.6% to close at $4.44 after the company reported worse-than-expected Q1 EPS results.
    • Zhihu Inc. (NYSE:ZH) shares fell 12.6% to close at $1.52.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) fell 11.4% to close at $3.43. Gain Therapeutics presented preclinical data from its GBA Parkinson's Disease program. The results were highlighted in a poster presentation at the XXVII World Congress on Parkinson's Disease and Related Disorders.
    • Farmer Bros. Co. (NASDAQ:FARM) dropped 10.6% to close at $5.89 following Q3 results.
    • Primerica, Inc. (NYSE:PRI) declined 10.6% to close at $115.93 following downbeat quarterly results.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) fell 10.5% to close at $3.08 after the company reported worse-than-expected Q1 sales results.
    • Teradata Corporation (NYSE:TDC) fell 10.2% to close at $35.84 after the company issued weak earnings forecast.
    • bluebird bio, Inc. (NASDAQ:BLUE) dropped 8.1% to close at $3.73.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) fell 7.5% to close at $1.74.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ACRX
    $AERI
    $AMLX

    CompanyDatePrice TargetRatingAnalyst
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    Cloudflare Inc.
    $NET
    2/4/2026$199.00Neutral → Buy
    BTIG Research
    RxSight Inc.
    $RXST
    1/30/2026Mkt Perform
    William Blair
    Bloom Energy Corporation
    $BE
    1/28/2026$153.00Equal Weight
    Barclays
    Bloom Energy Corporation
    $BE
    1/28/2026$207.00Buy
    China Renaissance
    Remitly Global Inc.
    $RELY
    1/27/2026$17.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ACOR
    $ACRX
    $AERI
    $AMLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 30, 2024 - FDA Roundup: July 30, 2024

    For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party C

    7/30/24 3:38:18 PM ET
    $GH
    Medical Specialities
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Watsa V Prem Et Al bought $4,888,139 worth of Class A Common Shares (776,291 units at $6.30) and bought $11,557,575 worth of Class C Common Shares (1,864,814 units at $6.20) (SEC Form 4)

    4 - Under Armour, Inc. (0001336917) (Issuer)

    1/29/26 6:18:29 PM ET
    $UAA
    Apparel
    Consumer Discretionary

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    Large owner Jobson Charles E bought $174,780 worth of Common (17,478 units at $10.00), increasing direct ownership by 1% to 1,639,149 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    1/27/26 8:45:38 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Bloom Energy with a new price target

    TD Cowen reiterated coverage of Bloom Energy with a rating of Hold and set a new price target of $160.00 from $105.00 previously

    2/6/26 8:24:09 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    BMO Capital Markets reiterated coverage on Bill.com with a new price target

    BMO Capital Markets reiterated coverage of Bill.com with a rating of Market Perform and set a new price target of $46.00 from $50.00 previously

    2/6/26 6:48:02 AM ET
    $BILL
    EDP Services
    Technology

    fuboTV upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded fuboTV from Neutral to Buy and set a new price target of $3.00

    2/5/26 6:51:39 AM ET
    $FUBO
    Movies/Entertainment
    Consumer Discretionary

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

    4 - Century Therapeutics, Inc. (0001850119) (Issuer)

    2/5/26 4:14:34 PM ET
    $IPSC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vice President of Sales Miller Brian David covered exercise/tax liability with 2,360 shares, decreasing direct ownership by 5% to 42,640 units (SEC Form 4)

    4 - FARMER BROTHERS CO (0000034563) (Issuer)

    2/5/26 4:08:57 PM ET
    $FARM
    Packaged Foods
    Consumer Staples

    Chief Operating Officer Kennedy Keith was granted 74,474 shares and covered exercise/tax liability with 4,644 shares, increasing direct ownership by 50% to 209,139 units (SEC Form 4)

    4 - CareDx, Inc. (0001217234) (Issuer)

    2/4/26 4:24:52 PM ET
    $CDNA
    Medical Specialities
    Health Care

    $ACOR
    $ACRX
    $AERI
    $AMLX
    SEC Filings

    View All

    Adtalem Global Education Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Covista Inc. (0000730464) (Filer)

    2/6/26 5:15:17 PM ET
    $ATGE
    Other Consumer Services
    Real Estate

    FuboTV Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - FuboTV Inc. (0001484769) (Filer)

    2/6/26 4:45:30 PM ET
    $FUBO
    Movies/Entertainment
    Consumer Discretionary

    SEC Form 10-Q filed by Under Armour Inc.

    10-Q - Under Armour, Inc. (0001336917) (Filer)

    2/6/26 9:04:57 AM ET
    $UAA
    Apparel
    Consumer Discretionary

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Farmer Brothers Coffee to report fiscal second quarter 2026 financial results

    FORT WORTH, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Farmer Brothers Coffee Co. (NASDAQ:FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today it will publish its second quarter 2026 financial results for the period ended Dec. 31, 2025 with the filing of its 10-Q and the issuing of its earnings results release, both of which will be posted on the Investor Relations section of its website after the close of market on Friday, Feb. 13. The company will also host an audio-only investor conference call and webcast at 5 p.m. Eastern on Friday, Feb. 13. During the call management will provide a review of the quarter and business update. The live

    2/6/26 4:10:00 PM ET
    $FARM
    Packaged Foods
    Consumer Staples

    Remitly to Report Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

    SEATTLE , Feb. 06, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of financial services that transcend borders, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 18, 2026. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast Information:When: We

    2/6/26 10:00:00 AM ET
    $RELY
    Real Estate

    Ubiquiti Inc. Reports Second Quarter Fiscal 2026 Financial Results

    ~ Record Revenues of $814.9 million, up 35.8% YoY ~ ~ GAAP Diluted Earnings Per Share of $3.86 ~ Ubiquiti Inc. (NYSE:UI) ("Ubiquiti" or the "Company") today announced its financial results for the second quarter ended December 31, 2025. Second Quarter Fiscal 2026 Financial Summary Revenues of $814.9 million GAAP diluted EPS of $3.86 Non-GAAP diluted EPS of $3.88 Additional Financial Highlight The Company's Board of Directors declared a $0.80 per share cash dividend payable on February 23, 2026 to shareholders of record at the close of business on February 17, 2026. Financial Highlights ($, in millions, except per share data) Income statement highlights  

    2/6/26 7:09:00 AM ET
    $UI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Leadership Updates

    Live Leadership Updates

    View All

    BellRing Brands Announces Leadership Transition Plan

    ST. LOUIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (the "Company") today announced that its President and Chief Executive Officer Darcy Davenport has decided to retire from the Company, effective upon the earlier of the appointment of a new Chief Executive Officer or September 30, 2026, the end of the Company's fiscal year. Ms. Davenport will continue to serve as President and Chief Executive Officer and as a member of the Board until the effective date of the transition, after which she will serve in an advisory role to ensure a smooth transition of leadership responsibilities and provide strategic support. The Board has commenced a comprehensive external sear

    2/3/26 7:01:00 AM ET
    $BRBR
    Packaged Foods
    Consumer Staples

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Realtor.com® Unveils Realtor.com®+™: A First-of-Its-Kind Collaborative Home Search Experience

    The platform is now live for Canopy MLS with 16 total MLS agreements signed and going live soonLive and signed agreements represent over 122,000 professionalsThe largest multi-MLS, co-branded portal collaboration of its kind since online data sharing began, keeping MLSs and professionals at the heart of the real estate ecosystemSigned integrations with leading agent and MLS technology providers, including Realtors Property Resource®, Docusign and HoverAUSTIN, Texas, Jan. 21, 2026 /PRNewswire/ -- Realtor.com® today announced the public debut of Realtor.com®+™, (pronounced "plus"), a collaborative home search platform built in collaboration with MLSs that helps real estate professionals and co

    1/21/26 11:00:00 AM ET
    $NWS
    $NWSA
    Newspapers/Magazines
    Consumer Discretionary

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Financials

    Live finance-specific insights

    View All

    Farmer Brothers Coffee to report fiscal second quarter 2026 financial results

    FORT WORTH, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Farmer Brothers Coffee Co. (NASDAQ:FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today it will publish its second quarter 2026 financial results for the period ended Dec. 31, 2025 with the filing of its 10-Q and the issuing of its earnings results release, both of which will be posted on the Investor Relations section of its website after the close of market on Friday, Feb. 13. The company will also host an audio-only investor conference call and webcast at 5 p.m. Eastern on Friday, Feb. 13. During the call management will provide a review of the quarter and business update. The live

    2/6/26 4:10:00 PM ET
    $FARM
    Packaged Foods
    Consumer Staples

    Remitly to Report Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

    SEATTLE , Feb. 06, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of financial services that transcend borders, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 18, 2026. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast Information:When: We

    2/6/26 10:00:00 AM ET
    $RELY
    Real Estate

    Ubiquiti Inc. Reports Second Quarter Fiscal 2026 Financial Results

    ~ Record Revenues of $814.9 million, up 35.8% YoY ~ ~ GAAP Diluted Earnings Per Share of $3.86 ~ Ubiquiti Inc. (NYSE:UI) ("Ubiquiti" or the "Company") today announced its financial results for the second quarter ended December 31, 2025. Second Quarter Fiscal 2026 Financial Summary Revenues of $814.9 million GAAP diluted EPS of $3.86 Non-GAAP diluted EPS of $3.88 Additional Financial Highlight The Company's Board of Directors declared a $0.80 per share cash dividend payable on February 23, 2026 to shareholders of record at the close of business on February 17, 2026. Financial Highlights ($, in millions, except per share data) Income statement highlights  

    2/6/26 7:09:00 AM ET
    $UI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ACOR
    $ACRX
    $AERI
    $AMLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care